Summary unavailable.

Questions

Question 1

What is the primary therapeutic use for most nonopioid analgesics as described in the text?

View answer and explanation
Question 2

For what specific condition is the nonopioid analgesic phenazopyridine used?

View answer and explanation
Question 3

What is the primary peripheral mechanism of action for the analgesic effect of most nonopioid analgesics?

View answer and explanation
Question 4

How does the mechanism of action of tramadol differ from that of most other nonopioid analgesics discussed?

View answer and explanation
Question 5

What potential risk is associated with the long-term use of acetaminophen in combination with NSAIDs?

View answer and explanation
Question 6

What is the potential effect of taking prolonged, high-doses of acetaminophen on a patient who is also taking warfarin?

View answer and explanation
Question 7

NSAIDs are known to increase the risk of bleeding when taken concurrently with several other drug classes. With which specific NSAID is this effect greatest?

View answer and explanation
Question 8

What is a potential interaction when NSAIDs are taken concurrently with diuretics or antihypertensive medications?

View answer and explanation
Question 9

The concurrent use of tramadol with other substances like alcohol, antihistamines, or sedative/hypnotics increases the risk of what adverse effect?

View answer and explanation
Question 10

Which patient group is identified as having an increased risk for developing hypersensitivity reactions to nonopioid analgesics?

View answer and explanation
Question 11

What is the primary effect of aspirin and most NSAIDs on bleeding time?

View answer and explanation
Question 12

To minimize the potential for gastric irritation, what is the recommended way to administer oral salicylates and NSAIDs?

View answer and explanation
Question 13

Unless otherwise directed by a health care professional, what is the maximum recommended duration for an adult to take acetaminophen?

View answer and explanation
Question 14

What is the maximum duration children should take acetaminophen for, unless directed by a health care professional?

View answer and explanation
Question 15

What is the minimum number of daily alcoholic drinks that may increase the risk of GI bleeding when consumed concurrently with salicylates or NSAIDs?

View answer and explanation
Question 16

What guidance should be provided to a patient on long-term salicylate or NSAID therapy who is scheduled for surgery?

View answer and explanation
Question 17

What administration technique is recommended for patients taking salicylates and NSAIDs to minimize esophageal irritation?

View answer and explanation
Question 18

What are the two primary desired outcomes for a patient receiving therapy with nonopioid analgesics?

View answer and explanation
Question 19

What is the specific mechanism by which most nonopioid analgesics achieve their antipyretic (fever-reducing) effect?

View answer and explanation
Question 20

What specific precaution is highlighted for the use of the nonopioid analgesic Tramadol?

View answer and explanation
Question 21

What is a primary contraindication for the use of NSAIDs, as stated in the text?

View answer and explanation
Question 22

In which of the following patient populations should nonopioid analgesics be used with caution?

View answer and explanation
Question 23

Hepatotoxicity from nonopioid analgesics may be additive when used with which substances?

View answer and explanation
Question 24

During prolonged high-dose therapy with nonopioid analgesics, which three types of organ system function should be periodically evaluated?

View answer and explanation
Question 25

To assess for potential GI blood loss during prolonged high-dose therapy with nonopioid analgesics, what specific laboratory value should be monitored?

View answer and explanation
Question 26

Under what circumstance is it acceptable for a patient to concurrently take acetaminophen, salicylates, or NSAIDs for more than a few days?

View answer and explanation
Question 27

How is the nonopioid analgesic capsaicin typically administered?

View answer and explanation
Question 28

According to the nursing implications, which set of parameters should be used to assess pain before and after administering a nonopioid analgesic?

View answer and explanation
Question 29

When assessing a patient for fever before and after the administration of a nonopioid analgesic, what associated signs should the nurse specifically note?

View answer and explanation
Question 30

Patients who are allergic to tartrazine are noted to be at an increased risk for developing what type of adverse reaction to nonopioid analgesics?

View answer and explanation
Question 31

What is the primary role of nonopioid analgesics in prostaglandin synthesis when providing their antipyretic effect?

View answer and explanation
Question 32

In addition to prolonging bleeding time by suppressing platelet aggregation, what other hematologic effect can large doses of aspirin and most NSAIDs cause?

View answer and explanation
Question 33

What specific patient instruction is provided to prevent analgesic nephropathy?

View answer and explanation
Question 34

The analgesic effect of most non-opioid analgesics is primarily achieved through which mechanism?

View answer and explanation
Question 35

What is the nature of the interaction between NSAIDs and certain cephalosporins or valproates?

View answer and explanation
Question 36

According to the 'Patient/Family Teaching' instructions, for how long should a patient remain in an upright position after taking salicylates or NSAIDs?

View answer and explanation
Question 37

What is the rationale for monitoring a patient's hematocrit periodically during prolonged high-dose NSAID therapy?

View answer and explanation
Question 38

What is a potential adverse effect of using non-opioid analgesics in a patient with a history of malnutrition?

View answer and explanation
Question 39

Which statement accurately reflects the patient teaching regarding the concurrent use of alcohol and salicylates?

View answer and explanation
Question 40

When a patient on prolonged high-dose NSAID therapy is being monitored, which laboratory evaluations are specifically recommended?

View answer and explanation
Question 41

What is the reason that patients with asthma are considered at increased risk for developing hypersensitivity reactions to nonopioid analgesics?

View answer and explanation
Question 42

What is the recommended patient action regarding short-term doses of acetaminophen taken with salicylates or NSAIDs?

View answer and explanation
Question 43

A patient asks if they should stop taking their daily low-dose aspirin before a dental procedure. Based on the text's guidance for surgery, what is the best advice?

View answer and explanation
Question 44

What is the maximum duration for which an adult should self-medicate with acetaminophen before consulting a health care professional?

View answer and explanation
Question 45

Phenazopyridine is identified as a nonopioid analgesic used for what specific purpose?

View answer and explanation
Question 46

In the context of nonopioid analgesics, what is the primary application of Capsaicin?

View answer and explanation
Question 47

Through which primary mechanism does Tramadol exert its analgesic effect?

View answer and explanation
Question 48

Additive hepatotoxicity is a concern when acetaminophen is taken with alcohol or what other category of substances?

View answer and explanation
Question 49

The increased risk of CNS depression when tramadol is used with other CNS depressants is due to what specific property of tramadol?

View answer and explanation
Question 50

What is the recommended administration method for oral salicylates to minimize gastric irritation?

View answer and explanation

Other chapters

HOW TO USE DAVIS'S DRUG GUIDE FOR NURSESEVIDENCE-BASED PRACTICE AND PHARMACOTHERAPEUTICS: Implications for NursesPHARMACOGENOMICSMEDICATION ERRORS: Improving Practices and Patient SafetyDETECTING AND MANAGING ADVERSE DRUG REACTIONSOVERVIEW OF RISK EVALUATION AND MITIGATION SYSTEMS (REMS)SPECIAL DOSING CONSIDERATIONSTHE CYTOCHROME P450 SYSTEMEDUCATING PATIENTS ABOUT SAFE MEDICATION USEAnti-Alzheimer's agentsAntianemicsAntianginalsAntianxiety agentsAntiarrhythmicsAntiasthmaticsAnticholinergicsAnticoagulantsAnticonvulsantsAntidepressantsAntidiabeticsAntidiarrhealsAntiemeticsAntifungalsAntihistaminesAntihypertensivesAnti-infectivesAntineoplasticsAntiparkinson agentsAntiplatelet agentsAntipsychoticsAntipyreticsAntirheumaticsAntiulcer agentsAntiviralsBeta blockersBone resorption inhibitorsBronchodilatorsCalcium channel blockersCentral nervous system stimulantsCorticosteroidsDiureticsHormonesImmunosuppressantsLaxativesLipid lowering agentsMinerals/electrolytes/pH modifiersNonsteroidal anti-inflammatory agentsOpioid analgesicsSedative/hypnoticsSkeletal muscle relaxantsThrombolyticsVaccines/immunizing agentsVitaminsDRUGS APPROVED IN CANADANATURAL/HERBAL PRODUCTSMEDICATION SAFETY TOOLSAppendix A. Recent Drug ApprovalsAppendix E. Administering Medications to ChildrenAppendix G. Pediatric Dosage CalculationsAppendix I. Controlled Substance SchedulesAppendix L. Insulins and Insulin TherapyAppendix M. Canadian and U.S. Pharmaceutical PracticesAppendix N. Routine Pediatric and Adult Immunizations